Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Dilon Acquires Navigator Gamma Probe Company

By Medimaging International staff writers
Posted on 13 Jan 2014
Print article
Dilon Technologies, Inc. (Newport News, VA, USA) has acquired the assets of the Navigator gamma probe business from RMD Instruments Corp. (Watertown, MA, USA), a subsidiary of Dynasil Corporation of America.

RMD Instruments manufactures and sells a range of intraoperative surgical probes that are distributed both in the United States and worldwide. The acquired products are used in surgery for procedures such as pulmonary wedge resection and sentinel lymph node biopsy. The company recently introduced its Navigator 2.0 wireless probe, which has been very well received by the market place.

“In addition to our market leadership in the small field-of-view molecular breast imaging market, this acquisition is consistent with our objective of expanding our product offering in both the diagnostic and surgical segments of the market and comes on the heels of our recent agreement with Digirad [Suwanee, GA, USA],” commented Robert G. Moussa, Dilon’s CEO.

“We are pleased to have found a wonderful home for our Navigator Probe technology, one of the most widely used gamma probes for cancer surgery in the marketplace. Dilon Technologies is well situated to expand the gamma probe market and we look forward to working with them over the coming months to transition the product from our manufacturing facility to Dilon,” commented Peter Sulick, Dynasil’s chairman and interim CEO.

Dynasil, for the time being, will continue to manufacture and distribute the products, maintaining continuity in supply and regulatory compliance.

Dilon Technologies’ keystone product, the Dilon molecular imaging system (MBI), is a high-resolution, small field-of-view digital gamma camera, optimized for MBI/breast-specific gamma imaging (BSGI). MBI utilizes radiotracer uptake to detect the increased metabolic activity of breast lesions and therefore, is not affected by breast density. Both the Dilon 6800 and Acella systems provide high photon sensitivity; and Dilon’s GammaLoc system is the only localization device on the market to enable molecular-guided breast biopsy.

Digirad is one of the largest US providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers, and also sells medical diagnostic imaging systems for nuclear cardiology and general nuclear medicine applications.

Related Links:

Dilon Technologies
RMD Instruments
Digirad



Print article
Radcal

Channels

Radiography

view channel
Image: The CAD platform is available on the Aspire Cristalle digital mammography system (Photo courtesy of Fujifilm).

CAD Solution Available on New Digital Mammography System

An industry-leading provider of cancer detection, radiation therapy, and workflow solutions, has announced that the company's mammography CAD solution is now available on a new advanced Full Field Digital... Read more

Ultrasound

view channel
Image: The SonoSite SII portable, mountable ultrasound system (Photo courtesy of Fujifilm SonoSite).

Mountable Ultrasound System Empowers Clinical Efficiency

A new ultrasound system developed for regional anesthesia, vascular access, and trauma applications provides a smart user interface that adapts to the user’s imaging needs. The SonoSite SII is a portable,... Read more

Nuclear medicine

view channel

PET/CT Nuclear Medicine System to Improve Cancer Detection and Treatment in Tunisia

The delivery of the first combined Positron Emission Tomography Computed Tomography (PET/CT) advanced imaging system to Tunisia is set to benefit cancer patients in the country. The system combines CT technology, which can accurately localize a tumor, with nuclear medicine (PET), which provides radiologists with information... Read more

General/Advanced Imaging

view channel

Early Intervention with Stent Retrievers Improves Outcomes for Ischemic Stroke Patients

New research has shown that restoration of blood flow to the brain within two and a half hours from the onset of the first signs of acute ischemic stroke resulted in none, or only minimal disability in 91% of patients. Endovascular therapy in the early stages of the onset of stroke symptoms significantly improved functional... Read more

Imaging IT

view channel

World Medical VR Technology Company Unveils First-of-Its-Kind Neurosurgery Surgical Visualization Platform

A novel neurosurgery Virtual Reality (VR) visualization platform has been demonstrated at the NVIDIA GPU Technology Conference (GTC) 2016 in California (USA). The enterprise-wide solution is intended to help clinicians plan, prepare, and perform neurosurgery, and enable the surgeon to empower and engage their patients... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.